Navigation Links
Orexigen® Therapeutics Reports Second Quarter Ended June 30, 2011 Financial Results
Date:8/8/2011

continuing the dispute resolution process because we strongly believe that there is a patient population for Contrave that has a risk:benefit profile that justifies approval without results from a cardiovascular outcomes trial," stated Mike Narachi, Orexigen President and CEO.  "Importantly, we have prioritized the pursuit of additional assets and are optimistic in these business development efforts."  

About Orexigen TherapeuticsWe are a biopharmaceutical company focused on expanding our pipeline of product candidates through one or more in-license, asset acquisitions or merger transactions where we can leverage our management team, cash and other resources.  Our strategy stems from feedback received from the U.S. Food and Drug Administration, or FDA, concerning substantial additional development requirements for our lead product candidate, Contrave.  Contrave has completed Phase III clinical trials, and our other product candidate, Empatic™, has completed Phase II clinical trials.  Each of the components of our product candidates has already received regulatory approval and has been commercialized previously.  We are appealing the FDA's additional development requirements for Contrave through the formal dispute resolution process. Further information about the Company can be found at www.orexigen.com.

Forward-Looking Statements  Orexigen cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements.  Words such as "believes," "anticipates," "plans," "expects," "indicates," "will," "intends," "potential," "suggests," "assuming," "designed" and similar expressions are intended to identify forward-looking statements.  These statements are based on the Company's current beliefs and expectations.  These forward-looking statements include statements regarding substantially lower c
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Orexigen® Therapeutics Announces FDA Acceptance of Contrave® New Drug Application for the Treatment of Obesity
2. Orexigen® Therapeutics Schedules August 5, 2010 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2010
3. Orexigen® Therapeutics Announces Publication of COR-I Phase 3 Study of Contrave in Lancet
4. Orexigen® Therapeutics COR-BMOD Study Published in the Journal Obesity
5. Orexigen® Therapeutics and Takeda Enter Into Partnership to Commercialize Contrave® in North America
6. Orexigen® Therapeutics to Speak at Rodman & Renshaw Annual Global Investment Conference
7. Orexigen® Therapeutics to Speak at Fifth Annual JMP Securities Healthcare Conference
8. Orexigen® Therapeutics Reports Third Quarter 2010 Financial Results
9. Orexigen® Therapeutics Investigational Drug Contrave® Receives Positive Recommendation from FDA Advisory Committee for Treatment of Obesity
10. Orexigen® Therapeutics, Inc. Announces Upcoming Departure of Chief Financial Officer
11. Orexigen® Therapeutics Schedules March 10, 2011 Webcast Discussion of Financial Results for the Fourth Quarter and Year Ended December 31, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... , Sept. 23, 2014 Research and ... (HbA1c) Testing Market" report to their offering. ... rate across the globe. Over 382 million people are estimated ... likely to increase to 592 million by 2035. With ... China and India ...
(Date:9/23/2014)... 2014 The Pennsylvania State Police will accept unwanted, ... part of National Prescription Drug Take-Back Day. The service ... Take-Back Day is a national initiative, conducted in partnership ... encouraging the public to dispose of expired, unused or ... theft. From 10 a.m. to 2 p.m., ...
(Date:9/23/2014)... September 23, 2014 ... the addition of the  "Large Volume Wearable ... offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... market holds significant potential for the future. ... painful needles to the modern-day pre-filled syringes, ...
Breaking Medicine Technology:Glycated Haemoglobin (HbA1c) Testing Market 2Glycated Haemoglobin (HbA1c) Testing Market 3Large Volume Wearable Injectors - 2nd Edition 2Large Volume Wearable Injectors - 2nd Edition 3Large Volume Wearable Injectors - 2nd Edition 4Large Volume Wearable Injectors - 2nd Edition 5
... N.J., Sept. 13, 2011 BD (Becton, Dickinson and ... medical technology company, today announced a commitment to Pink ... and private investments in global health to combat cervical ... Institute, the President,s Emergency Plan for AIDS Relief (PEPFAR), ...
... Calif., Sept. 13, 2011 BioMarin Pharmaceutical Inc. (Nasdaq: ... Officer of BioMarin, will present a company update at the ... September 20, 2011 at 12:30 p.m. ET.   ... conference call via the investor section of the BioMarin website, ...
Cached Medicine Technology:BD to Increase Access to Vital Cervical Cancer Screening in Resource-Limited Settings Through Commitment to Pink Ribbon Red Ribbon Initiative® 2BD to Increase Access to Vital Cervical Cancer Screening in Resource-Limited Settings Through Commitment to Pink Ribbon Red Ribbon Initiative® 3BD to Increase Access to Vital Cervical Cancer Screening in Resource-Limited Settings Through Commitment to Pink Ribbon Red Ribbon Initiative® 4BioMarin to Present at the UBS Global Life Sciences Conference 2
(Date:9/23/2014)... By Kathleen Doheny ... -- For babies born at very low birth weights, breast ... to a potentially dangerous infection known as cytomegalovirus (CMV), a ... very low birth weight infants -- all of whom weighed ... mothers with a history of CMV infection, to see whether ...
(Date:9/23/2014)... Sept. 23, 2014 (HealthDay News) -- Both drinking and ... factors for alcohol abuse by high school students, a ... survey of high school students who drink, could help ... who already drink, to stop them from becoming binge ... between age of first alcohol use and progression to ...
(Date:9/23/2014)... September 23, 2014 What information ... The National Quality Forum (NQF) released a report ... ), and an infographic ( http://bit.ly/1tX3lzA ) resulting ... of healthcare, how patients define affordability, and what ... get the best possible healthcare at the lowest ...
(Date:9/23/2014)... News) -- Few children who take medication for ... the rates vary six-fold across counties in the ... alone can manage symptoms for many children with ... receive behavioral therapy (psychotherapy), the Rand Corp. researchers ... than 1,500 counties across the United States that ...
(Date:9/23/2014)... obese as teenagers could grow up to earn up ... weight. So says Petter Lundborg of Lund University, Paul ... University and Lund University, all in Sweden. The team ... the United States, and the results are published in ... analyzed large-scale data of 145,193 Swedish-born brothers who enlisted ...
Breaking Medicine News(10 mins):Health News:Breast Milk a Risk for Spreading Common Virus to Preemies, Study Finds 2Health News:Breast Milk a Risk for Spreading Common Virus to Preemies, Study Finds 3Health News:Younger Age at First Drink, Higher Odds for Problem Drinking: Study 2Health News:Younger Age at First Drink, Higher Odds for Problem Drinking: Study 3Health News:Finding Affordable Care: Asking the Right Question is Key 2Health News:Kids Taking ADHD Drugs Get Little Psychotherapy: Study 2Health News:Note to young men: Fat doesn't pay 2
... satellite imagery also provides crash data in public policy effort ... You can now find the deadliest road in your town ... program that aims to increase public awareness of the need ... Minnesota,s Center for Excellence in Rural Safety (CERS) developed www.saferoadmaps.org, ...
... in the developing world may have substantially underestimated ... findings suggest that policymakers in low-income and middle-income ... impact that dementia places on their health services. ... population increases, dementia and other age-related illnesses are ...
... July 26 The following is a,transcript of the radio ... Good morning. This week, Congress voted to expand a,vital program ... Plan for AIDS Relief, also known as PEPFAR. I thank ... with my Administration to,pass this important bill, and I will ...
... being,issued by the Democratic National Committee:, (Logo: ... of the National Council on Disabilities, and,Bob Kafka, ... today in,advance of John McCain,s appearance via satellite ... Ohio. There is speculation that Senator,McCain will follow ...
... discuss second quarter financial results -, LAVAL, QC, ... today announced that it will host a conference call ... its second quarter 2008,financial results. Labopharm will report its ... 7:00 a.m. the same day., To access the ...
... immune response after antiretroviral therapy may be due to ... A new study challenges the long-held belief that the ... to restore itself after HIV patients are treated with ... to 90 percent of HIV-infected drug users are also ...
Cached Medicine News:Health News:Researchers Map America's Deadliest Roads 2Health News:Prevalence of dementia in the developing world underestimated 2Health News:Prevalence of dementia in the developing world underestimated 3Health News:Radio Address by President Bush to the Nation 2Health News:Radio Address by President Bush to the Nation 3Health News:AUDIO OF CONFERENCE CALL: National Disability Rights Leaders Dubious Over John McCain's Possible Switch on Community Choice Act, Says DNC 2Health News:Labopharm to host conference call Friday, August 8, 2008 at 8:30 A.M. (ET) 2Health News:Study Disproves Belief That Hepatitis C Blunts HIV Drugs 2
... and Cronin, Inc. is ... Patient Footwear, Orthopedic Softgoods, ... Products. Our products are ... and available in the ...
Perfect for use in the E.R. Stabilizes collateral ligament strains in seconds and allows hand and finger function. Made from 1/8" AliPlast™ PXE. Can be scissor trimmed....
... Control of thumb motion can be difficult ... for persons with spinal cord injuries and ... to cerebral palsy or other motor or ... the thumb for control and coordination. Soft ...
... Splints offer support without the restriction of ... pain or strain due to repetitive stress ... rigid or the flexible stay to provide ... and breathable, the ThumWrap Splint is comfortable ...
Medicine Products: